Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.47 |
| ▸ | ALPL | P05186 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 3/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.43 |
| ▸ | POLB | P06746 | 2/20 | 0.43 |
| ▸ | HTT | P42858 | 1/20 | 0.43 |
| ▸ | MAPK10 | P53779 | 1/20 | 0.43 |
| ▸ | AAK1 | Q2M2I8 | 1/20 | 0.43 |
| ▸ | GAA | P10253 | 3/20 | 0.42 |
| ▸ | NOS2 | P35228 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | GFER | P55789 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31716322 | 0.79 | SIRT2 (0.49) | KDM4EALDH1A1MAPK10GAANOS2 | |
| SCHEMBL28878057 | 0.75 | KDM4E (0.53) | KDM4EMEN1KMT2AALDH1A1POLB | |
| SCHEMBL7481213 | 0.74 | KDM4E (0.61) | KDM4EMEN1KMT2AALDH1A1POLB | |
| SCHEMBL20993621 | 0.73 | KDM4E (0.51) | KDM4EMEN1KMT2AALDH1A1POLB | |
| SCHEMBL7482211 | 0.72 | KDM4E (0.59) | KDM4EMEN1KMT2AALDH1A1POLB | |
| SCHEMBL31716585 | 0.71 | KDM4E (0.41) | KDM4EMEN1KMT2AALDH1A1POLB | |
| SCHEMBL31716884 | 0.71 | CYP11B2 (0.41) | KDM4EMEN1KMT2AALDH1A1HTT | |
| SCHEMBL31716033 | 0.71 | GAA (0.47) | KDM4EALPLMEN1KMT2AALDH1A1 | |
| SCHEMBL8637152 | 0.70 | GAA (0.64) | KDM4EMEN1KMT2APOLBHTT | |
| SCHEMBL25237063 | 0.68 | NOS2 (0.56) | NOS2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025227032-A1 | METHODS FOR DEGRADATION OF CYCLIN K AND INHIBITION OF CYCLIN DEPENDENT KINASES | REMIX THERAPEUTICS INC. (US) | 2025-10-30 | — | — | WO | disclosed |